TP53 and breast carcinoma: The latter is associated with metastasis and a poor outcome in TNBC [90] and has been shown to act through competition with miR-200a-3p in hepatocellular carcinoma [2,91], which is part of the miR-200 family/p53 axis of EMT regulation in breast cancer [23].